Sean Wharton
University of Toronto1 paperORCID 0000-0003-0111-1530OpenAlex
Papers
The New England Journal of MedicineHuman trial
Survodutide reduces weight in adults with diabetes and obesity
Weekly survodutide cut body weight by up to 9.8% at 76 weeks compared to a 3.9% reduction with placebo.Weekly survodutide cut body weight by up to 9.8% at 76 weeks compared to a 3.9% reduction with placebo.